Increased Expression of ProBDNF/Sortilin in Localized Prostate Cancer Tissues Compared to Adjacent Non-Cancerous...

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Prostate cancer (PCa) progression is linked to the unprocessed precursor of brain-derived neurotrophic factor (proBDNF).
• ProBDNF interacts with co-receptors sortilin and p75 neurotrophin receptor (p75NTR), influencing cell survival and apoptosis.
• Elevated proBDNF and sortilin correlate with castration resistance and metastasis in PCa, predicting poor therapeutic response.

Purpose of the Study:

• To investigate the tissue expression of proBDNF, sortilin, and p75NTR in prostate cancer.
• To determine the relationship between these proteins and PCa characteristics.

Main Methods:

• Immunohistochemical analysis was performed on 18 radical prostatectomy specimens.
• Matched para-carcinoma tissues were used as controls.
• Protein expression levels of proBDNF, sortilin, and p75NTR were quantified.

Main Results:

• Prostate cancer tissues exhibited significantly higher proBDNF expression compared to para-carcinoma tissues (p < 0.05).
• Sortilin expression was also significantly upregulated in PCa tissues (p < 0.01).
• p75NTR expression was low in both cancerous and non-cancerous tissues, though higher in PCa (p < 0.05).

Conclusions:

• Findings suggest a correlation between proBDNF, sortilin, p75NTR expression and PCa characteristics.
• These proteins may play a role in PCa development and progression.
• Further research into these interactions could inform targeted PCa therapy development.